1. Obituary for Professor Michael Steurer

   • Alexander Egle

   obituary 02 May 2019 Pages: 103 - 104

   

2. Overcoming resistance and bypassing checkpoints—possible new therapeutic frontiers in oncology

   • Andreas Pircher

   editorial 27 June 2019 Pages: 105 - 106

3. Saving lives with lung cancer screening

   • Wolfgang Hilbe
   • Andreas Pircher

   editorial 27 June 2019 Pages: 107 - 108

4. memo—publisher’s report 2018

   • Alois Sillaber

   editorial 03 April 2019 Pages: 109 - 110

   

5. Educational no.5: next-generation gene panel sequencing

   • Wolfgang Kranewitter

   educational 21 February 2019 Pages: 111 - 114

   

6. Direct oral anticoagulants: a treatment option in oncological patients

   • Johannes B. Jaeger
   • Thomas Jaeger
   • Clemens Feistritzer

   special report Open access 20 March 2019 Pages: 115 - 118

   

7. Investigation of seasonal frequency and pathogens in febrile neutropenia

   • Seray Karagöz Özdemir
   • Utku Iltar
   • Levent Undar

   original report 15 January 2019 Pages: 119 - 122

   

8. Resistance to immune checkpoint inhibitors. Next steps and combinational approaches

   • Thorsten Fuereder

   short review Open access 17 May 2019 Pages: 123 - 127

   

9. Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in mutated non-small cell lung cancer: new avenues and strategies to overcome resistance

   • Gudrun Absenger

   short review 18 April 2019 Pages: 128 - 135

   

10. Resistance to anti-hormonal therapy in prostate cancer

    • Zoran Culig

    short review Open access 12 June 2019 Pages: 136 - 139

11. Resistance in gastrointestinal stromal tumors

    • Andreas Seeber
    • Alexander Perathoner
    • Florian Kocher

    short review Open access 18 April 2019 Pages: 140 - 143

12. Resistance to chemotherapy and anti-angiogenic therapy in ovarian cancer

    • Verena Wieser
    • Christian Marth

    review Open access 21 February 2019 Pages: 144 - 148

13. Response assessment in non-small cell lung cancer immunotherapy: initial experiences in utilizing FDG PET/CT and the PD-1 blocker nivolumab

    • Diego Kauffmann-Guerrero
    • Andreas Schindler
    • Kathrin Kahnert

    original report 29 May 2019 Pages: 149 - 155

    

14. Tobacco control: prevention and cessation in Europe

    • Manfred Neuberger

    short review Open access 02 April 2019 Pages: 156 - 161

    

15. Whom to screen? A view on lung cancer screening from the pneumologist’s perspective

    • Malte Asshoff
    • Günter Weiss
    • Ivan Tancevski

    short review Open access 05 June 2019 Pages: 162 - 165

16. Challenges in implementation of lung cancer screening—radiology requirements

    • Gerlig Widmann

    short review Open access 10 May 2019 Pages: 166 - 170

17. Lung cancer screening—the surgeon’s perspective

    • Caecilia Ng
    • Herbert Maier
    • Florian Augustin

    short review Open access 18 June 2019 Pages: 171 - 174

    

18. Lung cancer screening from the oncologist’s perspective

    • Florian Kocher
    • Georg Pall

    short review Open access 17 May 2019 Pages: 175 - 178

19. Seasonal fever for 11 years! A presentation of hemophagocytic lymphohistiocytosis secondary to marginal zone lymphoma

    • Abhishek Chaturvedi
    • Muhammad Salman Faisal
    • Prerna Mewawalla

    case report 26 April 2019 Pages: 179 - 183

    

20. Correction to: Seasonal fever for 11 years! A presentation of hemophagocytic lymphohistiocytosis secondary to marginal zone lymphoma

    • Abhishek Chaturvedi
    • Muhammad Salman Faisal
    • Prerna Mewawalla

    Correction 23 May 2019 Pages: 184 - 184

21. Solitary scalp metastatic lesion as a sign of breast cancer recurrence—a case report

    • Ahmed A. M. Abdelhafeez
    • Wael Ibrahim
    • Wessam Elsherief

    case report 29 January 2019 Pages: 185 - 188